Activation	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
phosphatase	B-protein
inhibitors	O
involves	O
the	O
phosphorylation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
at	O
phosphatase	B-protein
2A-sensitive	I-protein
sites	I-protein
.	O

Activation	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
various	O
cellular	O
stimuli	O
involves	O
the	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
its	O
inhibitor	O
,	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
,	O
although	O
the	O
underlying	O
mechanism	O
remains	O
unclear	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
role	O
of	O
serine/threonine	B-protein
phosphatases	I-protein
in	O
the	O
regulation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
phosphorylation	O
was	O
investigated	O
.	O

Our	O
studies	O
demonstrate	O
that	O
incubation	O
of	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
with	O
low	O
concentrations	O
(	O
approximately	O
1-5	O
nM	O
)	O
of	O
calyculin	O
A	O
or	O
okadaic	O
acid	O
,	O
potent	O
inhibitors	O
of	O
protein	B-protein
phosphatase	I-protein
type	I-protein
1	I-protein
(	I-protein
PP-1	I-protein
)	I-protein
and	I-protein
type	I-protein
2A	I-protein
(	O
PP-2A	B-protein
)	O
,	O
induces	O
the	O
phosphorylation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
even	O
in	O
the	O
absence	O
of	O
any	O
cellular	O
stimulus	O
.	O

This	O
action	O
of	O
the	O
phosphatase	O
inhibitors	O
,	O
which	O
is	O
associated	O
with	O
the	O
activation	O
of	O
the	O
RelA.p50	B-protein
NF-kappa	I-protein
B	I-protein
heterodimer	I-protein
,	O
is	O
not	O
affected	O
by	O
agents	O
that	O
block	O
the	O
induction	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
phosphorylation	O
by	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
.	O

Furthermore	O
,	O
the	O
phosphorylated	B-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
from	O
calyculin	B-cell_line
A-treated	I-cell_line
cells	I-cell_line
,	O
but	O
not	O
that	O
from	O
TNF-alpha-stimulated	B-cell_line
cells	I-cell_line
,	O
is	O
sensitive	O
to	O
PP-2A	B-protein
in	O
vitro	O
,	O
suggesting	O
the	O
existence	O
of	O
fundamental	O
differences	O
in	O
the	O
phosphorylation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
induced	O
by	O
the	O
two	O
different	O
NF-kappa	B-protein
B	I-protein
inducers	O
.	O

However	O
,	O
induction	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
phosphorylation	O
by	O
both	O
TNF-alpha	B-protein
and	O
the	O
phosphatase	O
inhibitors	O
is	O
associated	O
with	O
the	O
subsequent	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

We	O
further	O
demonstrate	O
that	O
TNF-alpha-	O
and	O
calyculin	O
A-induced	O
I	O
kappa	O
B	O
alpha	O
degradation	O
exhibits	O
similar	O
but	O
not	O
identical	O
sensitivities	O
to	O
a	O
proteasome	O
inhibitor	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
phosphorylation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
,	O
mediated	O
through	O
both	O
the	O
TNF-alpha	B-protein
-inducible	O
and	O
the	O
PP-2A-opposing	B-protein
kinases	I-protein
,	O
may	O
serve	O
to	O
target	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
for	O
proteasome	B-protein
-mediated	O
degradation	O
.	O

Tex	NULL
JournaL	NULL
or	NULL
BroLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

31	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
4	NULL
,	NULL
pp	NULL
.	NULL

18347-18351	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
Phosphatase	NULL
Inhibitors	NULL
Involves	NULL
the	NULL
Phosphorylation	NULL
of	NULL
IxBa	NULL
at	NULL
Phosphatase	NULL
2A-sensitive	NULL
Sites*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
7	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
8	NULL
,	NULL
1995	NULL
)	NULL
Shao-Cong	NULL
Sunt	NULL
,	NULL
Sanjay	NULL
B.	NULL
Maggirwar	NULL
,	NULL
and	NULL
Edward	NULL
Harhaj	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Pennsylvania	NULL
State	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hershey	NULL
Medical	NULL
Center	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
850	NULL
,	NULL
Hershey	NULL
,	NULL
Pennsylvania	NULL
17033	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
various	NULL
cellular	NULL
stimuli	NULL
involves	NULL
the	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
,	NULL
although	NULL
the	NULL
underlying	NULL
mechanism	NULL
remains	NULL
unclear	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
role	NULL
of	NULL
serine/threonine	NULL
phosphatases	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
was	NULL
investigated	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
incubation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
low	NULL
concentrations	NULL
(	NULL
~1-5	NULL
nm	NULL
)	NULL
of	NULL
calyculin	NULL
A	NULL
or	NULL
okadaic	NULL
acid	NULL
,	NULL
potent	NULL
inhibitors	NULL
of	NULL
protein	NULL
phosphatase	NULL
type	NULL
1	NULL
(	NULL
PP-1	NULL
)	NULL
and	NULL
type	NULL
2A	NULL
(	NULL
PP-2A	NULL
)	NULL
,	NULL
induces	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
cellular	NULL
stimulus	NULL
.	NULL

This	NULL
action	NULL
of	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RelA-p50	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
,	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
agents	NULL
that	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
phosphorylated	NULL
I	NULL
«	NULL
Ba	NULL
from	NULL
calyculin	NULL
A-treated	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
that	NULL
from	NULL
TNF-a-stimulated	NULL
cells	NULL
,	NULL
is	NULL
sensitive	NULL
to	NULL
PP-2A	NULL
in	NULL
vitro	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
fundamental	NULL
differences	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
the	NULL
two	NULL
different	NULL
inducers	NULL
.	NULL

However	NULL
,	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
both	NULL
TNF-a	NULL
and	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
TNF-a-	NULL
and	NULL
calyculin	NULL
A-induced	NULL
IxBa	NULL
degradation	NULL
exhibits	NULL
similar	NULL
but	NULL
not	NULL
identical	NULL
sensitivities	NULL
to	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
,	NULL
mediated	NULL
through	NULL
both	NULL
the	NULL
TNF-a	NULL
«	NULL
-inducible	NULL
and	NULL
the	NULL
PP-2A-opposing	NULL
kinases	NULL
,	NULL
may	NULL
serve	NULL
to	NULL
target	NULL
I	NULL
«	NULL
Ba	NULL
for	NULL
proteasome-mediated	NULL
degradation	NULL
.	NULL

The	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
various	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
immediate	NULL
early	NULL
processes	NULL
of	NULL
immune	NULL
,	NULL
acute	NULL
phase	NULL
,	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
viruses	NULL
,	NULL
most	NULL
notably	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immune	NULL
deficiency	NULL
virus	NULL
(	NULL
HIV-1	NULL
)	NULL
'	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
corresponds	NULL
to	NULL
a	NULL
set	NULL
of	NULL
hetero-	NULL
or	NULL
homodimeric	NULL
complexes	NULL
composed	NULL
of	NULL
a	NULL
family	NULL
of	NULL
related	NULL
polypeptides	NULL
.	NULL

In	NULL
higher	NULL
vertebrates	NULL
,	NULL
this	NULL
family	NULL
includes	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
RelA	NULL
(	NULL
previously	NULL
termed	NULL
p65	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
all	NULL
of	NULL
which	NULL
contain	NULL
an	NULL
N-termi-nal	NULL
domain	NULL
of	NULL
homology	NULL
(	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
~300	NULL
amino	NULL
*This	NULL
study	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
IRG-196	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

£	NULL
Scholar	NULL
of	NULL
the	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
717-531-4164	NULL
;	NULL
Fax	NULL
:	NULL
717-531-6522	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HIV-1	NULL
,	NULL
type	NULL
1	NULL
human	NULL
immune	NULL
deficiency	NULL
virus	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
PP-1	NULL
,	NULL
PP-2A	NULL
,	NULL
and	NULL
PP-2B	NULL
,	NULL
phosphatase	NULL
type	NULL
1	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
2B	NULL
,	NULL
respectively	NULL
;	NULL
TPCK	NULL
,	NULL
tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidinedithiocarbamate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
IxBa-P	NULL
,	NULL
phosphorylated	NULL
IxBa	NULL
.	NULL

acids	NULL
;	NULL
Refs	NULL
.	NULL

8-15	NULL
,	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

16	NULL
and	NULL
17	NULL
)	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
predominant	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
RelA	NULL
.	NULL

This	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
normally	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
by	NULL
physical	NULL
association	NULL
with	NULL
an	NULL
inhibitory	NULL
protein	NULL
,	NULL
termed	NULL
IxBa	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
IxBa	NULL
specifically	NULL
binds	NULL
to	NULL
and	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
RelA	NULL
,	NULL
thereby	NULL
preventing	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
RelA	NULL
:	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

The	NULL
latent	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
can	NULL
be	NULL
posttransla-tionaly	NULL
activated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
stimuli	NULL
,	NULL
including	NULL
mitogens	NULL
like	NULL
phorbol	NULL
esters	NULL
,	NULL
cytokines	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
interleukin-1	NULL
,	NULL
and	NULL
the	NULL
Tax	NULL
protein	NULL
from	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

17	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
these	NULL
various	NULL
inducers	NULL
involves	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
,	NULL
concomitant	NULL
with	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
liberated	NULL
NF-kB	NULL
heterodimer	NULL
(	NULL
24-30	NULL
)	NULL
.	NULL

The	NULL
biologically	NULL
active	NULL
nuclear	NULL
NF-kB	NULL
complex	NULL
in	NULL
turn	NULL
activates	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
large	NULL
set	NULL
of	NULL
cellular	NULL
genes	NULL
encoding	NULL
not	NULL
only	NULL
various	NULL
factors	NULL
involved	NULL
in	NULL
immune	NULL
stimulation	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
cell	NULL
growth	NULL
but	NULL
also	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitor	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
24	NULL
,	NULL
25	NULL
,	NULL
31-34	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
subject	NULL
to	NULL
tight	NULL
control	NULL
by	NULL
an	NULL
autoregulatory	NULL
feedback	NULL
mechanism	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
degradation	NULL
of	NULL
IxBa	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
the	NULL
proteasome	NULL
complex	NULL
(	NULL
85	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
degrading	NULL
enzymes	NULL
within	NULL
the	NULL
proteasome	NULL
are	NULL
constitutively	NULL
active	NULL
and	NULL
that	NULL
the	NULL
inducible	NULL
degradation	NULL
of	NULL
IxBa	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
posttranslational	NULL
modification	NULL
of	NULL
IxBa	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
degradation	NULL
of	NULL
IkBa	NULL
,	NULL
induced	NULL
by	NULL
various	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
,	NULL
is	NULL
preceded	NULL
by	NULL
the	NULL
transient	NULL
phosphorylation	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
(	NULL
30	NULL
,	NULL
36-39	NULL
)	NULL
,	NULL
thus	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
phosphorylation	NULL
may	NULL
serve	NULL
to	NULL
target	NULL
IxBa	NULL
for	NULL
subsequent	NULL
degradation	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
proposal	NULL
,	NULL
kinase	NULL
activators	NULL
like	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
such	NULL
as	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
40-43	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
calyculin	NULL
A	NULL
or	NULL
okadaic	NULL
acid	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

Furthermore	NULL
,	NULL
unlike	NULL
TNF-a	NULL
,	NULL
calyculin	NULL
A	NULL
induces	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
at	NULL
sites	NULL
that	NULL
are	NULL
sensitive	NULL
to	NULL
PP-2A	NULL
.	NULL

However	NULL
,	NULL
as	NULL
observed	NULL
with	NULL
TNF-a	NULL
«	NULL
,	NULL
calyculin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
the	NULL
subsequent	NULL
proteasome-mediated	NULL
degradation	NULL
of	NULL
this	NULL
inhibitory	NULL
protein	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
differential	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
may	NULL
target	NULL
this	NULL
inhibitor	NULL
for	NULL
degradation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
and	NULL
Reagents-Human	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
were	NULL
purchased	NULL
from	NULL
LC	NULL
Laboratories	NULL
(	NULL
Woburn	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
and	NULL
pyrrolidinedithioccarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

TNF-a	NULL
and	NULL
the	NULL
purified	NULL
serine/threonine	NULL
phosphatases	NULL
,	NULL
PP-1	NULL
,	NULL
PP-2A	NULL
,	NULL
and	NULL
PP-2B	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
18347	NULL
18348	NULL
¥04	NULL
-a	NULL
‘	NULL
H	NULL
M	NULL
4__r~1F-xfls/DNA	NULL
complex	NULL
bb	NULL
ARRIS	NULL
A	NULL
%	NULL
t	NULL
»	NULL
%	NULL
.	NULL

%	NULL
s	NULL
®	NULL
zoos/4,0	NULL
.	NULL

Og	NULL
A	NULL
{	NULL
743/9	NULL
calyculin	NULL
A	NULL
IxBa*	NULL
IxBa	NULL
/	NULL
\	NULL
\	NULL
%	NULL
%	NULL
1	NULL
[	NULL
/	NULL
bod	NULL
ba	NULL
i+	NULL
bul	NULL
vi	NULL
C	NULL
CC	NULL
L	NULL
0	NULL
3	NULL
Is	NULL
I	NULL
5	NULL
<	NULL
8	NULL
)	NULL
5p	NULL
(	NULL
min	NULL
)	NULL
_g__	NULL
NF-	NULL
«	NULL
B/DNA	NULL
complex	NULL
calyculin	NULL
A	NULL
okadaic	NULL
acid	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
RelA	NULL
:	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
by	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
involves	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

A	NULL
,	NULL
antibody	NULL
super	NULL
shift	NULL
analysis	NULL
of	NULL
calyculin	NULL
A-induced	NULL
nuclear	NULL
NF-kB	NULL
complex	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
either	NULL
untreated	NULL
(	NULL
NT	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
calyculin	NULL
A-treated	NULL
(	NULL
25	NULL
nM	NULL
for	NULL
1	NULL
h	NULL
,	NULL
lanes	NULL
2-7	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-radiolabeled	NULL
kB	NULL
probe	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
NF-kB	NULL
species	NULL
in	NULL
the	NULL
DNA-protein	NULL
complex	NULL
,	NULL
specific	NULL
antisera	NULL
recognizing	NULL
different	NULL
NF-kB	NULL
subunits	NULL
(	NULL
Zanes	NULL
4-7	NULL
)	NULL
or	NULL
a	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
(	NULL
PF	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
included	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

The	NULL
major	NULL
super	NULL
shifted	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

B	NULL
,	NULL
the	NULL
time	NULL
course	NULL
analysis	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
25	NULL
ni	NULL
calyculin	NULL
A	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
or	NULL
25	NULL
nM	NULL
okadaic	NULL
acid	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
,	NULL
isolated	NULL
from	NULL
these	NULL
cells	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
an	NULL
IxBa-specific	NULL
antiserum	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
EMSA	NULL
using	NULL
the	NULL
*°P-labeled	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

IxBa*	NULL
is	NULL
a	NULL
modified	NULL
form	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

Biotechnology	NULL
,	NULL
Inc	NULL
.	NULL

The	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
MyoGenics	NULL
Inc.	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Immunoblotting	NULL
and	NULL
Electrophoresis	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Jurkat	NULL
T	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
subjected	NULL
to	NULL
preparation	NULL
of	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
(	NULL
44	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
(	NULL
~15	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
reducing	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
immunoreactivity	NULL
with	NULL
a	NULL
peptide-specific	NULL
antiserum	NULL
recognizing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
human	NULL
I	NULL
«	NULL
Ba	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

For	NULL
phosphatase	NULL
treatment	NULL
,	NULL
the	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
0.5	NULL
units	NULL
of	NULL
the	NULL
indicated	NULL
specific	NULL
serine/threonine	NULL
phosphatases	NULL
or	NULL
20	NULL
units	NULL
of	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
nuclear	NULL
extracts	NULL
(	NULL
~3	NULL
ug	NULL
)	NULL
with	NULL
a	NULL
*°P-radiolabeled	NULL
high	NULL
affinity	NULL
palindromic	NULL
kB	NULL
probe	NULL
,	NULL
«	NULL
B-pd	NULL
(	NULL
45	NULL
)	NULL
followed	NULL
by	NULL
resolving	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
on	NULL
native	NULL
5	NULL
%	NULL
poly-acrylamide	NULL
gels	NULL
.	NULL

For	NULL
antibody	NULL
``	NULL
super	NULL
shift	NULL
``	NULL
assays	NULL
,	NULL
1	NULL
wl	NULL
of	NULL
anti-peptide	NULL
antiserum	NULL
specifically	NULL
recognizing	NULL
each	NULL
of	NULL
the	NULL
NF-kB	NULL
subunits	NULL
was	NULL
added	NULL
to	NULL
the	NULL
EMSA	NULL
reaction	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
electrophoresis	NULL
.	NULL

RESULTS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
by	NULL
Phosphatase	NULL
Inhibitors	NULL
Involves	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
of	NULL
IrxBa-As	NULL
described	NULL
above	NULL
,	NULL
the	NULL
phosphatase	NULL
inhibitor	NULL
calyculin	NULL
A	NULL
induces	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Using	NULL
antibody	NULL
super	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
NF-kB	NULL
species	NULL
in	NULL
the	NULL
kB-binding	NULL
protein	NULL
complex	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
a	NULL
major	NULL
DNA-protein	NULL
complex	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
calyculin	NULL
A-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
Induction	NULL
of	NULL
IkBa	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
incubation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
mixtures	NULL
with	NULL
either	NULL
a	NULL
p50-specific	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
a	NULL
RelA-specific	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
antiserum	NULL
resulted	NULL
in	NULL
the	NULL
supershift	NULL
of	NULL
the	NULL
kB	NULL
binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
arrowheads	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
p50	NULL
and	NULL
RelA	NULL
in	NULL
this	NULL
complex	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
this	NULL
NF-	NULL
«	NULL
B/DNA	NULL
complex	NULL
only	NULL
slightly	NULL
immunore-acted	NULL
with	NULL
anti-c-Rel	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
and	NULL
had	NULL
no	NULL
immunoreactivity	NULL
with	NULL
either	NULL
anti-p52	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
a	NULL
control	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
calyculin	NULL
A-induced	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
contains	NULL
predominantly	NULL
the	NULL
p50-RelA	NULL
heterodimer	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
underlying	NULL
mechanism	NULL
of	NULL
this	NULL
induction	NULL
event	NULL
,	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
calyculin	NULL
A	NULL
on	NULL
the	NULL
fate	NULL
of	NULL
IxBa	NULL
,	NULL
a	NULL
major	NULL
cytoplasmic	NULL
inhibitor	NULL
regulating	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
p50-Rel¥A	NULL
NF-kB	NULL
heterodimer	NULL
.	NULL

In	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
single	NULL
37-kDa	NULL
form	NULL
of	NULL
IxBa	NULL
was	NULL
detected	NULL
with	NULL
an	NULL
IxBa-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
calyculin	NULL
A	NULL
(	NULL
25	NULL
nm	NULL
)	NULL
for	NULL
5	NULL
min	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
I	NULL
«	NULL
Ba	NULL
«	NULL
species	NULL
(	NULL
IxBa*	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
which	NULL
became	NULL
the	NULL
predominant	NULL
form	NULL
of	NULL
IxBa	NULL
after	NULL
15	NULL
min	NULL
of	NULL
incubation	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

The	NULL
slower	NULL
mobility	NULL
of	NULL
this	NULL
IxBa	NULL
species	NULL
was	NULL
apparently	NULL
the	NULL
result	NULL
of	NULL
phosphorylation	NULL
,	NULL
since	NULL
this	NULL
form	NULL
could	NULL
be	NULL
completely	NULL
converted	NULL
to	NULL
the	NULL
fast	NULL
migrating	NULL
37-kDa	NULL
species	NULL
by	NULL
in	NULL
vitro	NULL
incubation	NULL
with	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
calyculin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
led	NULL
to	NULL
the	NULL
subsequent	NULL
degradation	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
preexisting	NULL
IxBa	NULL
was	NULL
almost	NULL
depleted	NULL
at	NULL
60	NULL
min	NULL
posttreatment	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
(	NULL
25	NULL
nm	NULL
)	NULL
also	NULL
induced	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
,	NULL
albeit	NULL
with	NULL
delayed	NULL
kinetics	NULL
(	NULL
3-8	NULL
h	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
finding	NULL
that	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
exhibit	NULL
differential	NULL
kinetics	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
cellular	NULL
phosphatases	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Parallel	NULL
EMSA	NULL
studies	NULL
revealed	NULL
that	NULL
the	NULL
kinetics	NULL
of	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
correlated	NULL
with	NULL
that	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
expression	NULL
in	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
is	NULL
likely	NULL
mediated	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
IkxBa	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
.	NULL

Calyculin	NULL
A-induced	NULL
Phosphorylation	NULL
of	NULL
IxBa	NULL
Is	NULL
Not	NULL
Affected	NULL
by	NULL
Inhibitors	NULL
of	NULL
TNF-a	NULL
Signaling-Prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
by	NULL
various	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
,	NULL
such	NULL
as	NULL
TNF-a	NULL
,	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
chymotrypsin	NULL
type	NULL
of	NULL
protease	NULL
inhibitors	NULL
,	NULL
such	NULL
as	NULL
TPCK	NULL
,	NULL
and	NULL
reducing	NULL
agents	NULL
like	NULL
PDTC	NULL
(	NULL
30	NULL
,	NULL
36	NULL
,	NULL
47	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
role	NULL
of	NULL
chymotrypsin-like	NULL
proteases	NULL
and	NULL
reactive	NULL
oxygen	NULL
species	NULL
in	NULL
this	NULL
signaling	NULL
path-way	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
signaling	NULL
pathway	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
TPCK	NULL
and	NULL
PDTC	NULL
on	NULL
calyculin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
was	NULL
investigated	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
these	NULL
agents	NULL
,	NULL
calyculin	NULL
A	NULL
induced	NULL
both	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
TNF-a	NULL
(	NULL
30	NULL
)	NULL
,	NULL
preincubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
TPCK	NULL
did	NULL
not	NULL
affect	NULL
calyculin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
,	NULL
although	NULL
this	NULL
treatment	NULL
blocked	NULL
the	NULL
subsequent	NULL
degradation	NULL
of	NULL
the	NULL
IxBa-P	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
neither	NULL
phosphorylation	NULL
nor	NULL
degradation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
calyculin	NULL
A	NULL
was	NULL
affected	NULL
by	NULL
preincubating	NULL
the	NULL
cells	NULL
with	NULL
PDTC	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
calyculin	NULL
A	NULL
does	NULL
not	NULL
involve	NULL
the	NULL
signaling	NULL
steps	NULL
that	NULL
require	NULL
the	NULL
action	NULL
of	NULL
reactive	NULL
oxygen	NULL
species	NULL
or	NULL
chymotrypsin-like	NULL
proteases	NULL
.	NULL

A	NULL
PP-2A-opposing	NULL
Kinase	NULL
Appears	NULL
to	NULL
Mediate	NULL
the	NULL
Phosphorylation	NULL
of	NULL
IkBa	NULL
Induced	NULL
by	NULL
Calyculin	NULL
A	NULL
but	NULL
Not	NULL
That	NULL
Induced	NULL
by	NULL
TNF-a-To	NULL
further	NULL
explore	NULL
the	NULL
biochemical	NULL
mechanism	NULL
underlying	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
opposing	NULL
phosphatases	NULL
was	NULL
investigated	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
both	NULL
calyculin	NULL
A	NULL
and	NULL
Induction	NULL
of	NULL
IkBa	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
1	NULL
2	NULL
3	NULL
ole	NULL
-	NULL
&	NULL
``	NULL
,	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
I	NULL
IxBa-P	NULL
IxBa	NULL
83	NULL
,	NULL
.	NULL

I	NULL
,	NULL
&	NULL
4	NULL
”	NULL
)	NULL
¢	NULL
&	NULL
659	NULL
Is	NULL
4	NULL
%	NULL
3	NULL
5p	NULL
(	NULL
min	NULL
)	NULL
Cal	NULL
A	NULL
Cal	NULL
A	NULL
_	NULL
Cal	NULL
A	NULL
+	NULL
+	NULL
TPCK	NULL
_	NULL
PDTC	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
chymotrypsin	NULL
type	NULL
of	NULL
TPCK	NULL
protease	NULL
inhibitor	NULL
and	NULL
the	NULL
reducing	NULL
agent	NULL
PDTC	NULL
on	NULL
calyculin	NULL
A-induced	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
NT	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
with	NULL
25	NULL
nM	NULL
calyculin	NULL
A	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
50	NULL
pM	NULL
TPCK	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
or	NULL
200	NULL
um	NULL
PDTC	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

For	NULL
the	NULL
double	NULL
treatments	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
either	NULL
TPCK	NULL
for	NULL
30	NULL
min	NULL
or	NULL
PDTC	NULL
for	NULL
1	NULL
h	NULL
before	NULL
adding	NULL
calyculin	NULL
A	NULL
(	NULL
Cal	NULL
A	NULL
)	NULL
to	NULL
the	NULL
culture	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
the	NULL
IxBa-specific	NULL
antiserum	NULL
.	NULL

okadaic	NULL
acid	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
potently	NULL
inhibit	NULL
the	NULL
PP-2A	NULL
class	NULL
of	NULL
phosphatases	NULL
at	NULL
low	NULL
concentrations	NULL
is	NULL
0.5-1.0	NULL
nit	NULL
)	NULL
(	NULL
50	NULL
)	NULL
.	NULL

However	NULL
,	NULL
inhibition	NULL
of	NULL
PP-1	NULL
and	NULL
PP-2B	NULL
by	NULL
okadaic	NULL
acid	NULL
requires	NULL
much	NULL
higher	NULL
concentrations	NULL
(	NULL
IC	NULL
;	NULL
,	NULL
values	NULL
are	NULL
60-200	NULL
ni	NULL
and	NULL
10	NULL
un	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
phosphatases	NULL
negatively	NULL
regulating	NULL
IxBa	NULL
phosphorylation	NULL
,	NULL
concentration-depend	NULL
ent	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
was	NULL
performed	NULL
using	NULL
okadaic	NULL
acid	NULL
as	NULL
inducer	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
as	NULL
low	NULL
as	NULL
1	NULL
nm	NULL
okadaic	NULL
acid	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
IxBa-P	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
was	NULL
enhanced	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
between	NULL
1	NULL
and	NULL
50	NULL
nu	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
concentration	NULL
range	NULL
was	NULL
observed	NULL
with	NULL
calyculin	NULL
A	NULL
although	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
this	NULL
drug	NULL
was	NULL
achieved	NULL
within	NULL
a	NULL
shorter	NULL
time	NULL
period	NULL
(	NULL
30	NULL
min	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
12	NULL
h	NULL
,	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
these	NULL
phosphatase	NULL
inhibitors	NULL
is	NULL
probably	NULL
a	NULL
result	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
PP-2A	NULL
but	NULL
not	NULL
PP-1	NULL
or	NULL
PP-2B	NULL
type	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
this	NULL
possibil-ity	NULL
,	NULL
protein	NULL
extracts	NULL
isolated	NULL
from	NULL
calyculin	NULL
A-treated	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
vitro	NULL
with	NULL
various	NULL
purified	NULL
protein	NULL
phosphatases	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
the	NULL
IxBa-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
our	NULL
in	NULL
vivo	NULL
results	NULL
,	NULL
incubation	NULL
of	NULL
the	NULL
extract	NULL
with	NULL
PP-2A	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
PP-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
PP-2B	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
buffer	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
complete	NULL
conversion	NULL
of	NULL
the	NULL
IxBa-P	NULL
to	NULL
its	NULL
basal	NULL
form	NULL
.	NULL

A	NULL
similar	NULL
result	NULL
of	NULL
IxBa	NULL
dephosphorylation	NULL
was	NULL
obtained	NULL
with	NULL
okadaic	NULL
acid-treated	NULL
cell	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
results	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
of	NULL
IkBa	NULL
in	NULL
calyculin	NULL
A-	NULL
or	NULL
okadaic	NULL
acid-treated	NULL
cells	NULL
is	NULL
likely	NULL
mediated	NULL
by	NULL
a	NULL
protein	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
opposing	NULL
the	NULL
action	NULL
of	NULL
the	NULL
PP-2A	NULL
type	NULL
of	NULL
phosphatases	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
TNF-	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
also	NULL
opposed	NULL
by	NULL
the	NULL
action	NULL
of	NULL
the	NULL
PP-2A	NULL
type	NULL
of	NULL
phosphatases	NULL
,	NULL
in	NULL
vitro	NULL
dephosphorylation	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
protein	NULL
extract	NULL
isolated	NULL
from	NULL
TNF-a-stimulated	NULL
cells	NULL
and	NULL
the	NULL
various	NULL
serine/threonine	NULL
phosphatases	NULL
as	NULL
well	NULL
as	NULL
a	NULL
control	NULL
nonspecific	NULL
alkaline	NULL
phosphatase	NULL
,	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
CIP	NULL
,	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
observed	NULL
(	NULL
49	NULL
)	NULL
,	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
(	NULL
IxBa-P	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
was	NULL
readily	NULL
dephosphorylated	NULL
by	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
each	NULL
of	NULL
the	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
tested	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
form	NULL
of	NULL
IxBa-P	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
,	NULL
which	NULL
was	NULL
in	NULL
sharp	NULL
contrast	NULL
to	NULL
the	NULL
dephosphorylation	NULL
result	NULL
obtained	NULL
with	NULL
calyculin	NULL
A-induced	NULL
IxBa-P	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

While	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
physiological	NULL
phosphatases	NULL
opposing	NULL
the	NULL
action	NULL
of	NULL
TNF-a-induced	NULL
protein	NULL
kinases	NULL
remains	NULL
un-	NULL
18349	NULL
A	NULL
ana	NULL
fp	NULL
``	NULL
§	NULL
,	NULL
5	NULL
,	NULL
&	NULL
,	NULL
Ky	NULL
K	NULL
o	NULL
Y	NULL
bs	NULL
3	NULL
3	NULL
(	NULL
nM	NULL
)	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Io	NULL
4	NULL
od	NULL
IxBa-P	NULL
IxBa	NULL
2I345	NULL
E-	NULL
&	NULL
TNF-a	NULL
5	NULL
min	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
induced	NULL
by	NULL
calyculin	NULL
A	NULL
,	NULL
but	NULL
not	NULL
that	NULL
induced	NULL
by	NULL
TNF-a	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
negatively	NULL
regulated	NULL
by	NULL
PP-2A-like	NULL
phosphatases	NULL
.	NULL

A	NULL
,	NULL
concentration	NULL
dependence	NULL
of	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
okadaic	NULL
acid	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
for	NULL
12	NULL
h.	NULL
Whole-cell	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
the	NULL
IxBa-specific	NULL
antiserum	NULL
.	NULL

IkBa	NULL
and	NULL
its	NULL
phosphorylated	NULL
form	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
in	NULL
vitro	NULL
dephosphorylation	NULL
analyses	NULL
of	NULL
IxBa-P.	NULL
A	NULL
cytoplasmic	NULL
extract	NULL
isolated	NULL
from	NULL
either	NULL
calyculin	NULL
A-treated	NULL
(	NULL
A	NULL
,	NULL
25	NULL
nM	NULL
,	NULL
15	NULL
min	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
-treated	NULL
(	NULL
C	NULL
,	NULL
10	NULL
ng/ml	NULL
,	NULL
5	NULL
min	NULL
)	NULL
cells	NULL
was	NULL
incubated	NULL
in	NULL
vitro	NULL
with	NULL
either	NULL
a	NULL
control	NULL
buffer	NULL
or	NULL
the	NULL
indicated	NULL
phosphatases	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
using	NULL
the	NULL
IxBa-specific	NULL
antiserum	NULL
.	NULL

CIP	NULL
,	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

known	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
calyculin	NULL
A	NULL
and	NULL
TNF-	NULL
«	NULL
may	NULL
involve	NULL
different	NULL
protein	NULL
kinases	NULL
.	NULL

A	NULL
Proteasome	NULL
Inhibitor	NULL
Exhibits	NULL
a	NULL
Differential	NULL
Inhibitory	NULL
Effect	NULL
on	NULL
Calyculin	NULL
A-	NULL
and	NULL
TNF-a-stimulated	NULL
IkBa	NULL
Degrada-tion-Proteasome	NULL
inhibitors	NULL
,	NULL
including	NULL
MG132	NULL
(	NULL
MyoGenics	NULL
)	NULL
,	NULL
have	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
inhibit	NULL
TNF-	NULL
«	NULL
-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
multicatalytic	NULL
proteasome	NULL
complex	NULL
in	NULL
this	NULL
degradation	NULL
event	NULL
(	NULL
35	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
same	NULL
type	NULL
of	NULL
proteases	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
calyculin	NULL
A-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
MG132	NULL
on	NULL
IxBa	NULL
degradation	NULL
was	NULL
examined	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
calyculin	NULL
A	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
1	NULL
h	NULL
with	NULL
25	NULL
uM	NULL
MG132	NULL
completely	NULL
blocked	NULL
calyculin	NULL
A-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
upper	NULL
panel	NULL
;	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
with	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
a	NULL
parallel	NULL
EMSA	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
MG132	NULL
also	NULL
strongly	NULL
inhibited	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
upper	NULL
panel	NULL
;	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
with	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
observation	NULL
with	NULL
calyculin	NULL
A	NULL
,	NULL
MG132	NULL
failed	NULL
to	NULL
completely	NULL
block	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
TNF-	NULL
«	NULL
.	NULL

Indeed	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MG132	NULL
,	NULL
TNF-a	NULL
still	NULL
stimulated	NULL
slow	NULL
but	NULL
significant	NULL
loss	NULL
of	NULL
the	NULL
IxBa-P	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
upper	NULL
panel	NULL
;	NULL
compare	NULL
lane	NULL
9	NULL
with	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
along	NULL
with	NULL
the	NULL
degradation	NULL
of	NULL
IxBa-P	NULL
,	NULL
a	NULL
small	NULL
peptide	NULL
(	NULL
~20	NULL
kDa	NULL
)	NULL
appeared	NULL
in	NULL
the	NULL
cells	NULL
and	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
immunoblotting	NULL
with	NULL
the	NULL
anti-peptide	NULL
antiserum	NULL
reacting	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5	NULL
678|9|1|01|1	NULL
IxBa-P	NULL
e	NULL
2	NULL
IxBa	NULL
mame	NULL
meses	NULL
<	NULL
4-	NULL
Is	NULL
Bo-	NULL
C	NULL
e	NULL
1	NULL
“	NULL
w	NULL
_	NULL
,	NULL
--	NULL
~	NULL
complex	NULL
e	NULL
sz	NULL
p	NULL
o	NULL
ntr	NULL
4	NULL
%	NULL
``	NULL
3	NULL
8	NULL
%	NULL
*s	NULL
%	NULL
,	NULL
.	NULL

4+,6	NULL
0,8	NULL
b	NULL
.	NULL

3p	NULL
(	NULL
min	NULL
)	NULL
Cal	NULL
A	NULL
Cal	NULL
A	NULL
TNF-a	NULL
TNF-a	NULL
7	NULL
)	NULL
»	NULL
+	NULL
+	NULL
K	NULL
:	NULL
MG132	NULL
MGs	NULL
-	NULL
s	NULL
25	NULL
«	NULL
M	NULL
)	NULL
GM	NULL
-	NULL
3	NULL
%	NULL
,	NULL
2	NULL
.	NULL

4	NULL
j	NULL
P	NULL
4	NULL
,	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
on	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
50	NULL
nm	NULL
calyculin	NULL
A	NULL
(	NULL
Cal	NULL
A	NULL
)	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
10	NULL
ng/ml	NULL
TNF-a	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
.	NULL

For	NULL
the	NULL
double	NULL
treatments	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
MG132	NULL
and	NULL
then	NULL
further	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
calyculin	NULL
A	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
lanes	NULL
9-13	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
the	NULL
peptide-specific	NULL
antiserum	NULL
recognizing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
.	NULL

IxBa-C	NULL
is	NULL
likely	NULL
a	NULL
degradation	NULL
product	NULL
containing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
.	NULL

This	NULL
small	NULL
fragment	NULL
was	NULL
also	NULL
detected	NULL
with	NULL
a	NULL
different	NULL
antiserum	NULL
recognizing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

with	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
I	NULL
«	NULL
kBa	NULL
(	NULL
Zane	NULL
10	NULL
,	NULL
IxBa-C	NULL
)	NULL
.	NULL

This	NULL
peptide	NULL
was	NULL
apparently	NULL
the	NULL
C-terminal	NULL
degradation	NULL
product	NULL
of	NULL
IxBa	NULL
since	NULL
it	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
by	NULL
a	NULL
different	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C-terminal	NULL
peptide	NULL
of	NULL
IxBa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
this	NULL
degradation	NULL
product	NULL
was	NULL
likely	NULL
mediated	NULL
through	NULL
a	NULL
protease	NULL
insensitive	NULL
to	NULL
MG132	NULL
,	NULL
since	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
small	NULL
peptide	NULL
was	NULL
not	NULL
affected	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
higher	NULL
amounts	NULL
of	NULL
MG132	NULL
(	NULL
50	NULL
un	NULL
,	NULL
lane	NULL
11	NULL
,	NULL
and	NULL
75	NULL
un	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Parallel	NULL
EMSA	NULL
studies	NULL
revealed	NULL
that	NULL
MG132	NULL
also	NULL
failed	NULL
to	NULL
completely	NULL
block	NULL
TNF-	NULL
«	NULL
induction	NULL
of	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lower	NULL
panel	NULL
;	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
and	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

Calyculin	NULL
A	NULL
and	NULL
TNF-a	NULL
Exhibit	NULL
Synergistic	NULL
Action	NULL
in	NULL
the	NULL
Induction	NULL
of	NULL
IkBa	NULL
Degradation	NULL
and	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B-In	NULL
view	NULL
of	NULL
the	NULL
differential	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
TNF-a	NULL
and	NULL
calyculin	NULL
A	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
whether	NULL
these	NULL
two	NULL
inducers	NULL
had	NULL
synergistic	NULL
action	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
degradation	NULL
and	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
TNF-a	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
or	NULL
TNF-a	NULL
together	NULL
with	NULL
calyculin	NULL
A	NULL
(	NULL
lanes	NULL
8-12	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
IxBa	NULL
and	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
were	NULL
detected	NULL
by	NULL
immunoblotting	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
EMSA	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
TNF-a	NULL
led	NULL
to	NULL
the	NULL
transient	NULL
appearance	NULL
of	NULL
the	NULL
IkxBa-P	NULL
and	NULL
the	NULL
gradual	NULL
degradation	NULL
of	NULL
this	NULL
inhibitor	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
,	NULL
which	NULL
was	NULL
concomitant	NULL
with	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
(	NULL
10	NULL
ng	NULL
of	NULL
TNF-	NULL
«	NULL
/7	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
stimulation	NULL
for	NULL
30	NULL
min	NULL
led	NULL
to	NULL
the	NULL
degradation	NULL
of	NULL
only	NULL
about	NULL
50	NULL
%	NULL
of	NULL
the	NULL
IxBa	NULL
molecules	NULL
(	NULL
compare	NULL
lane	NULL
1	NULL
with	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
costimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
both	NULL
TNF-	NULL
«	NULL
and	NULL
calyculin	NULL
A	NULL
markedly	NULL
enhanced	NULL
the	NULL
rate	NULL
of	NULL
IxBa	NULL
degradation	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
8-12	NULL
)	NULL
.	NULL

Significant	NULL
loss	NULL
of	NULL
IxBa	NULL
was	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
10	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Zane	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
entire	NULL
intracellular	NULL
pool	NULL
of	NULL
IxBa	NULL
was	NULL
almost	NULL
depleted	NULL
at	NULL
30	NULL
min	NULL
(	NULL
Zane	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
enhanced	NULL
rate	NULL
of	NULL
IxBa	NULL
degradation	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
more	NULL
rapid	NULL
and	NULL
remarkably	NULL
higher	NULL
level	NULL
of	NULL
NF-kB	NULL
nuclear	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lower	NULL
panel	NULL
,	NULL
compare	NULL
lanes	NULL
2-6	NULL
with	NULL
lanes	NULL
8-12	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
depletion	NULL
of	NULL
IxBa	NULL
by	NULL
calyculin	NULL
A	NULL
alone	NULL
required	NULL
at	NULL
least	NULL
60	NULL
min	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
phosphatase	NULL
Induction	NULL
of	NULL
IkBa	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
1	NULL
.	NULL

20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Lod	NULL
d	NULL
o	NULL
d	NULL
U	NULL
o	NULL
”	NULL
a	NULL
.	NULL

eg	NULL
db	NULL
“	NULL
/IkBa-P	NULL
\	NULL
IxBa	NULL
¥	NULL
u	NULL
,	NULL
_	NULL
NF-KB/DNA	NULL
Complex	NULL
Kkkkk	NULL
TNF-a	NULL
TNF-a	NULL
+	NULL
Cal	NULL
A	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Synergy	NULL
between	NULL
calyculin	NULL
A	NULL
(	NULL
Cal	NULL
A	NULL
)	NULL
and	NULL
TNF-a	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
degradation	NULL
and	NULL
NF-kB	NULL
nuclear	NULL
expression	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
alone	NULL
(	NULL
lanes	NULL
2-6	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
together	NULL
with	NULL
25	NULL
nM	NULL
calyculin	NULL
A	NULL
(	NULL
lanes	NULL
8-12	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
the	NULL
IxBa-specific	NULL
antiserum	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
EMSA	NULL
using	NULL
the	NULL
*°P-labeled	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

inhibitor	NULL
calyculin	NULL
A	NULL
and	NULL
the	NULL
cytokine	NULL
TNF-a	NULL
have	NULL
synergistic	NULL
activity	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IkxBa	NULL
degradation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
The	NULL
nuclear	NULL
expression	NULL
and	NULL
biological	NULL
function	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
are	NULL
tightly	NULL
regulated	NULL
through	NULL
its	NULL
cytoplasmic	NULL
retention	NULL
by	NULL
the	NULL
ankyrin-rich	NULL
inhibitor	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
by	NULL
various	NULL
cellular	NULL
stimuli	NULL
involves	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
the	NULL
concomitant	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
liberated	NULL
NF-kB	NULL
heterodimer	NULL
(	NULL
24-30	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
biochemical	NULL
mechanism	NULL
underlying	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
remains	NULL
unclear	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
degradation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
various	NULL
mitogens	NULL
and	NULL
cytokines	NULL
occurs	NULL
in	NULL
association	NULL
with	NULL
the	NULL
transient	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
30	NULL
,	NULL
36-39	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
serine/threonine	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
also	NULL
induce	NULL
the	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
okadaic	NULL
acid	NULL
can	NULL
be	NULL
achieved	NULL
at	NULL
low	NULL
concentrations	NULL
(	NULL
1-5	NULL
nit	NULL
)	NULL
,	NULL
at	NULL
which	NULL
PP-2A	NULL
,	NULL
but	NULL
not	NULL
other	NULL
phosphatases	NULL
including	NULL
PP-1	NULL
and	NULL
PP-2B	NULL
,	NULL
is	NULL
able	NULL
to	NULL
be	NULL
inhibited	NULL
(	NULL
48	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
action	NULL
of	NULL
okadaic	NULL
acid	NULL
,	NULL
and	NULL
probably	NULL
also	NULL
calyculin	NULL
A	NULL
,	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
cellular	NULL
PP-2A	NULL
type	NULL
of	NULL
phosphatases	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
notion	NULL
,	NULL
the	NULL
IkxBa-P	NULL
produced	NULL
in	NULL
both	NULL
calyculin	NULL
A-and	NULL
okadaic	NULL
acid-treated	NULL
cells	NULL
can	NULL
be	NULL
readily	NULL
dephosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
PP-2A	NULL
but	NULL
not	NULL
by	NULL
PP-1	NULL
or	NULL
PP-2B	NULL
.	NULL

This	NULL
result	NULL
further	NULL
suggests	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
may	NULL
be	NULL
directly	NULL
mediated	NULL
by	NULL
a	NULL
PP-2A-opposing	NULL
protein	NULL
kinase	NULL
.	NULL

However	NULL
,	NULL
from	NULL
our	NULL
current	NULL
studies	NULL
,	NULL
we	NULL
are	NULL
not	NULL
certain	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinase	NULL
is	NULL
a	NULL
direct	NULL
result	NULL
of	NULL
PP-2A	NULL
inhibition	NULL
or	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
indirect	NULL
mechanism	NULL
that	NULL
,	NULL
for	NULL
example	NULL
,	NULL
may	NULL
involve	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
upstream	NULL
signaling	NULL
molecules	NULL
.	NULL

A	NULL
previous	NULL
study	NULL
has	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
okadaic	NULL
acid	NULL
can	NULL
be	NULL
partially	NULL
inhibited	NULL
by	NULL
the	NULL
antioxidant	NULL
cys-teine	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
reactive	NULL
oxygen	NULL
species	NULL
in	NULL
this	NULL
induction	NULL
process	NULL
(	NULL
42	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
present	NULL
study	NULL
is	NULL
not	NULL
in	NULL
full	NULL
agreement	NULL
with	NULL
these	NULL
previous	NULL
findings	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
phosphorylation	NULL
as	NULL
well	NULL
as	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
by	NULL
calyculin	NULL
A	NULL
(	NULL
25	NULL
nm	NULL
)	NULL
is	NULL
not	NULL
appreciably	NULL
inhibited	NULL
by	NULL
PDTC	NULL
,	NULL
a	NULL
potent	NULL
antioxidant	NULL
that	NULL
blocks	NULL
TNF-a-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
(	NULL
25	NULL
,	NULL
50	NULL
)	NULL
.	NULL

This	NULL
discrepancy	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
much	NULL
higher	NULL
concentration	NULL
(	NULL
2	NULL
ux	NULL
)	NULL
of	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
used	NULL
in	NULL
the	NULL
previous	NULL
study	NULL
.	NULL

At	NULL
this	NULL
concentration	NULL
,	NULL
both	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
will	NULL
nonspecifically	NULL
inhibit	NULL
most	NULL
types	NULL
of	NULL
the	NULL
serine/threonine	NULL
phosphatases	NULL
(	NULL
48	NULL
)	NULL
,	NULL
which	NULL
may	NULL
in	NULL
turn	NULL
trigger	NULL
additional	NULL
,	NULL
perhaps	NULL
antioxidant-sensitive	NULL
,	NULL
signaling	NULL
Induction	NULL
of	NULL
IxBa	NULL
Phosphorylation	NULL
and	NULL
Degradation	NULL
pathways	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
proposal	NULL
,	NULL
okadaic	NULL
acid	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
synergize	NULL
the	NULL
action	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
only	NULL
at	NULL
high	NULL
concentrations	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
more	NULL
recent	NULL
study	NULL
using	NULL
a	NULL
low	NULL
concentration	NULL
of	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
has	NULL
revealed	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
these	NULL
phosphatase	NULL
inhibitors	NULL
is	NULL
indeed	NULL
insensitive	NULL
to	NULL
antioxidants	NULL
(	NULL
43	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
induction	NULL
of	NULL
I	NULL
«	NULL
xBa	NULL
phosphorylation	NULL
by	NULL
calyculin	NULL
A	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
TPCK	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
the	NULL
chymotrypsin	NULL
type	NULL
of	NULL
proteases	NULL
that	NULL
blocks	NULL
TNF-	NULL
«	NULL
w-induced	NULL
IxBa	NULL
phosphorylation	NULL
(	NULL
30	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
may	NULL
either	NULL
bypass	NULL
the	NULL
signaling	NULL
steps	NULL
that	NULL
are	NULL
sensitive	NULL
to	NULL
TPCK	NULL
and	NULL
antioxidants	NULL
or	NULL
involve	NULL
a	NULL
signaling	NULL
pathway	NULL
that	NULL
is	NULL
different	NULL
from	NULL
that	NULL
triggered	NULL
by	NULL
TNF-	NULL
«	NULL
.	NULL

Our	NULL
data	NULL
favor	NULL
the	NULL
latter	NULL
possibility	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IxBa	NULL
«	NULL
-P	NULL
produced	NULL
in	NULL
TNF-a-treated	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
dephosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
PP-2A	NULL
,	NULL
although	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
this	NULL
phosphatase	NULL
proves	NULL
to	NULL
be	NULL
efficient	NULL
in	NULL
removing	NULL
the	NULL
phosphate	NULL
from	NULL
calyculin	NULL
A-induced	NULL
IxBa-P	NULL
.	NULL

Thus	NULL
,	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
these	NULL
two	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
distinct	NULL
kinases	NULL
.	NULL

However	NULL
,	NULL
a	NULL
more	NULL
conclusive	NULL
answer	NULL
to	NULL
this	NULL
question	NULL
awaits	NULL
the	NULL
precise	NULL
determination	NULL
of	NULL
the	NULL
phosphorylation	NULL
sites	NULL
within	NULL
these	NULL
two	NULL
types	NULL
of	NULL
I	NULL
«	NULL
Ba-P	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
inhibition	NULL
of	NULL
IxBa	NULL
degradation	NULL
by	NULL
certain	NULL
proteasome	NULL
inhibitors	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
the	NULL
IxBa-P	NULL
(	NULL
36-39	NULL
)	NULL
,	NULL
thus	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
may	NULL
target	NULL
this	NULL
inhibitor	NULL
for	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
one	NULL
potential	NULL
model	NULL
may	NULL
involve	NULL
phosphorylation	NULL
serving	NULL
as	NULL
a	NULL
molecular	NULL
trigger	NULL
to	NULL
alter	NULL
the	NULL
conformation	NULL
of	NULL
IkBa	NULL
,	NULL
thus	NULL
facilitating	NULL
the	NULL
action	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
proteases	NULL
.	NULL

According	NULL
to	NULL
this	NULL
scenario	NULL
,	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
different	NULL
sites	NULL
can	NULL
cause	NULL
distinct	NULL
conformational	NULL
changes	NULL
,	NULL
which	NULL
may	NULL
in	NULL
turn	NULL
lead	NULL
to	NULL
the	NULL
differential	NULL
sensitivities	NULL
of	NULL
IxBa	NULL
to	NULL
the	NULL
cellular	NULL
proteases	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
outcome	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

Spe-cifically	NULL
,	NULL
calyculin	NULL
A-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
can	NULL
be	NULL
completely	NULL
blocked	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
um	NULL
MG132	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
solely	NULL
the	NULL
MG132-sensitive	NULL
proteases	NULL
in	NULL
this	NULL
degradation	NULL
process	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TNF-	NULL
«	NULL
-induced	NULL
IxBa	NULL
degradation	NULL
appears	NULL
to	NULL
involve	NULL
additional	NULL
proteases	NULL
that	NULL
are	NULL
insensitive	NULL
to	NULL
MG132	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
up	NULL
to	NULL
75	NULL
um	NULL
of	NULL
MG132	NULL
,	NULL
partial	NULL
degradation	NULL
of	NULL
IxBa	NULL
still	NULL
occurs	NULL
in	NULL
TNF-a-stimulated	NULL
cells	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
a	NULL
small	NULL
degradation	NULL
product	NULL
(	NULL
~20	NULL
kDa	NULL
)	NULL
containing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
.	NULL

Of	NULL
course	NULL
,	NULL
it	NULL
remains	NULL
a	NULL
possibility	NULL
that	NULL
calyculin	NULL
A	NULL
and	NULL
TNF-a	NULL
both	NULL
induce	NULL
IxBa	NULL
kinases	NULL
and	NULL
up-regulate	NULL
cellular	NULL
proteases	NULL
,	NULL
which	NULL
act	NULL
coordinately	NULL
to	NULL
eliminate	NULL
IxBa	NULL
.	NULL

Nevertheless	NULL
,	NULL
from	NULL
our	NULL
current	NULL
studies	NULL
,	NULL
we	NULL
can	NULL
not	NULL
conclude	NULL
that	NULL
phosphorylation	NULL
targets	NULL
IkBa	NULL
for	NULL
degradation	NULL
.	NULL

Studies	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
precisely	NULL
map	NULL
the	NULL
phosphorylation	NULL
sites	NULL
within	NULL
the	NULL
I	NULL
«	NULL
xBa-P	NULL
,	NULL
which	NULL
will	NULL
allow	NULL
us	NULL
to	NULL
determine	NULL
the	NULL
biological	NULL
importance	NULL
of	NULL
phosphorylation	NULL
in	NULL
the	NULL
degradation	NULL
of	NULL
IxkBa	NULL
«	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Warner	NULL
Greene	NULL
for	NULL
the	NULL
IxBa-specific	NULL
antisera	NULL
and	NULL
MyoGenics	NULL
,	NULL
Inc.	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Cellular	NULL
Regulation	NULL
:	NULL
Hormonal	NULL
Control	NULL
Regulation	NULL
of	NULL
Gene	NULL
Transcription	NULL
(	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Foulkes	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

409-432	NULL
,	NULL
Elsevier/North-Holland	NULL
Biomedical	NULL
Press	NULL
,	NULL
Amsterdam	NULL
3	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
826	NULL
,	NULL
711-713	NULL
4	NULL
.	NULL

Kaufman	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Valanora	NULL
,	NULL
G.	NULL
,	NULL
Rodriguez	NULL
,	NULL
G.	NULL
,	NULL
Bushar	NULL
,	NULL
G.	NULL
,	NULL
Giri	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Norcross	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
3759-3766	NULL
w	NULL
co	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

38	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

18351	NULL
.	NULL

Muesing	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Capon	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
1575-1578	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Peterin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
6845-6849	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
348	NULL
,	NULL
76-80	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlisberger	NULL
,	NULL
U.	NULL
,	NULL
Lahm	NULL
,	NULL
H.-W.	NULL
,	NULL
Schlaeger	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
Schreidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
966-970	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Shcreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-968	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

of	NULL
Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1875-1879	NULL
Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
841-843	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
405-455	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1899-1913	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3	NULL
,	NULL
1339-1352	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
van	NULL
Zee	NULL
,	NULL
K.	NULL
,	NULL
Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Fanning	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
1121-1133	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
dos	NULL
Santos	NULL
Silva	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
201-211	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Granzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2532-2536	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1912-1915	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
V.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
3301-3310	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
L	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
182-185	NULL
Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11803-11810	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Ernst	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4685-4695	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Elwood	NULL
,	NULL
J.	NULL
,	NULL
Béraud	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7377-7384	NULL
Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1266-1276	NULL
de	NULL
Martin	NULL
,	NULL
R.	NULL
,	NULL
Vanhove	NULL
,	NULL
B.	NULL
,	NULL
Cheng	NULL
,	NULL
Q.	NULL
,	NULL
Hofer	NULL
,	NULL
E.	NULL
,	NULL
Csizmadia	NULL
,	NULL
V.	NULL
,	NULL
Winkler	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Bach	NULL
,	NULL
F.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2773-2779	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Schmidt-Ullrich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
5043-5049	NULL
Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
28-32	NULL
Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rando	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
773-785	NULL
Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A	NULL
,	NULL
9	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
11884-11888	NULL
Traenckner	NULL
,	NULL
E.	NULL
B.-M.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5433-5441	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1302-1311	NULL
Alkalay	NULL
,	NULL
L	NULL
,	NULL
Yaron	NULL
,	NULL
A.	NULL
,	NULL
Hatzubai	NULL
,	NULL
A.	NULL
,	NULL
Jung	NULL
,	NULL
S.	NULL
,	NULL
Avraham	NULL
,	NULL
A.	NULL
,	NULL
Gerlitz	NULL
,	NULL
O.	NULL
,	NULL
Pashut-Lavon	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1294-1301	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cel	NULL
{	NULL
47	NULL
,	NULL
921-928	NULL
Thévenin	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Rieckmann	NULL
,	NULL
P.	NULL
,	NULL
Fujiki	NULL
,	NULL
H.	NULL
,	NULL
Norcross	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Sporn	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
798-800	NULL
Menon	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Qin	NULL
,	NULL
S.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Tan	NULL
,	NULL
Y.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
26805-26812	NULL
Suzuki	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Mizuno	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Packer	NULL
,	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
5008-5015	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Hoffman	NULL
,	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
83-92	NULL
Deleted	NULL
in	NULL
proof	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
M.	NULL
,	NULL
Schmitt	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Hatanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
12740-12744	NULL
Ishihara	NULL
,	NULL
H.	NULL
,	NULL
Martin	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Brautigan	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Karaki	NULL
,	NULL
H.	NULL
,	NULL
Ozaki	NULL
,	NULL
H.	NULL
,	NULL
Kato	NULL
,	NULL
Y.	NULL
,	NULL
Fusetani	NULL
,	NULL
N.	NULL
,	NULL
Watabe	NULL
,	NULL
S.	NULL
,	NULL
Hashimoto	NULL
,	NULL
K.	NULL
,	NULL
Uemura	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Hartshorne	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

159	NULL
,	NULL
871-877	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Beraud	NULL
,	NULL
C.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
1346-1350	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL

